EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cellular Metabolic Heterogeneity and Therapeutic Targeting in Rheumatoid Arthritis

Sheng Chen iD, Yufan Luo, Qiuzhi Zhou, Hong Chen

Cells · 26.10.2026 · 15 (21) · 1949

DOI: 10.3390/cells15211949 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 26.10.2026. Verfasst von Sheng Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid. Die Arbeit nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic abnormalities in rheumatoid arthritis (RA) differ across cell populations and anatomical compartments. Glycolytic synovial fibroblasts coexist with blood T-cell populations showing impaired glycolytic induction or mitochondrial function, while macrophage metabolism can sustain inflammation or tissue protection. These differences complicate systemic metabolic inhibition. This narrative review integrates human RA studies, experimental arthritis and mechanistic work in other systems to identify dependencies that support defined pathogenic functions. We examine metabolite transport, nutrient adaptation and nutrient and energy sensing, distinguishing causal perturbation from descriptive signatures and preclinical hypotheses from clinical efficacy signals. Systemic cardiometabolic disease and nutritional interventions provide a clinical context for interpreting local metabolic findings. Small trials of repurposed drugs suggest possible benefit during treatment, but do not establish durable metabolic correction. We propose that a claim of reprogramming requires persistent functional change after drug removal, exclusion of residual exposure and selective cell loss, and preservation of immune regulation and host defence. These criteria could guide more selective metabolic interventions and their evaluation in patient tissue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidHumansAnimalsMetabolic Reprogramming

Stichwörter der Autor:innen

immunometabolismmetabolic heterogeneitymetabolic reprogrammingrheumatoid arthritissynovial fibroblasts

Autor:innen und Institutionen

  • Department of Rehabilitation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Stem Cell Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, Wuhan 430030, China.

ORCID-Profile: Sheng Chen

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Chen, S., Luo, Y., Zhou, Q., & Chen, H. (2026). Cellular Metabolic Heterogeneity and Therapeutic Targeting in Rheumatoid Arthritis. Cells, 15(21), 1949. https://doi.org/10.3390/cells15211949

Vancouver

Chen S, Luo Y, Zhou Q, Chen H. Cellular Metabolic Heterogeneity and Therapeutic Targeting in Rheumatoid Arthritis. Cells. 2026;15(21):1949. doi:10.3390/cells15211949

BibTeX
@article{Chen2026,
  author = {Chen, Sheng and Luo, Yufan and Zhou, Qiuzhi and Chen, Hong},
  title = {Cellular Metabolic Heterogeneity and Therapeutic Targeting in Rheumatoid Arthritis},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {21},
  pages = {1949},
  doi = {10.3390/cells15211949}
}
Kostenlos starten →